Literature DB >> 26212009

PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.

G Zhu1, X Li1, B Guo1, Q Ke2, M Dong3, F Li1.   

Abstract

The p21-activated kinase 5 (PAK5) is overexpressed in advanced cancer and the transcription factor E47 is a direct repressor of E-cadherin and inducer of epithelial-mesenchymal transition (EMT). However, the relationship between PAK5 and E47 has not been explored. In this study, we found that PAK5-mediated E47 phosphorylation promoted EMT in advanced colon cancer. PAK5 interacted with E47 and phosphorylated E47 on Ser39 under hepatocyte growth factor (HGF) stimulation, which decreased cell-cell cohesion, increased cell migration and invasion in vitro and promoted metastasis in a xenograft model. Furthermore, phosphorylation of E47 facilitated its accumulating in nucleus in an importin α-dependent manner, and enhanced E47 binding to E-cadherin promoter directly, leading to inhibition of E-cadherin transcription. In contrast, PAK5-knockdown resulted in blockage of HGF-induced E47 phosphorylation, attenuated association of E47 with importin α and decreased E47 binding to E-cadherin promoter. In addition, we demonstrated a close correlation between PAK5 and phospho-Ser39 E47 expression in colon cancer specimens. More importantly, high expression of phospho-E47 was associated with an aggressive phenotype of colon cancer and nuclear phospho-E47 staining was found in certain cases of colon cancer with metastasis. Collectively, E47 is a novel substrate of PAK5, and PAK5-mediated phosphorylation of E47 promotes EMT and metastasis of colon cancer, suggesting that phosphorylated E47 on Ser39 may be a potential therapeutic target in progressive colon cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26212009     DOI: 10.1038/onc.2015.259

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  PAK4 is activated via PI3K in HGF-stimulated epithelial cells.

Authors:  Claire M Wells; Arie Abo; Anne J Ridley
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

2.  Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation.

Authors:  S E Johnson; X Wang; S Hardy; E J Taparowsky; S F Konieczny
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions.

Authors:  Shawn W Cochrane; Ying Zhao; Robert S Welner; Xiao-Hong Sun
Journal:  Blood       Date:  2008-10-16       Impact factor: 22.113

4.  miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.

Authors:  W W Hwang-Verslues; P-H Chang; P-C Wei; C-Y Yang; C-K Huang; W-H Kuo; J-Y Shew; K-J Chang; E Y-H P Lee; W-H Lee
Journal:  Oncogene       Date:  2011-01-24       Impact factor: 9.867

Review 5.  PAK as a therapeutic target in gastric cancer.

Authors:  Xiaodong Li; Funan Liu; Feng Li
Journal:  Expert Opin Ther Targets       Date:  2010-04       Impact factor: 6.902

6.  Phosphorylation of E47 as a potential determinant of B-cell-specific activity.

Authors:  S R Sloan; C P Shen; R McCarrick-Walmsley; T Kadesch
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

7.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Authors:  Roland Schmitz; Ryan M Young; Michele Ceribelli; Sameer Jhavar; Wenming Xiao; Meili Zhang; George Wright; Arthur L Shaffer; Daniel J Hodson; Eric Buras; Xuelu Liu; John Powell; Yandan Yang; Weihong Xu; Hong Zhao; Holger Kohlhammer; Andreas Rosenwald; Philip Kluin; Hans Konrad Müller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Martin D Ogwang; Steven J Reynolds; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Stefania Pittaluga; Wyndham Wilson; Thomas A Waldmann; Martin Rowe; Sam M Mbulaiteye; Alan B Rickinson; Louis M Staudt
Journal:  Nature       Date:  2012-08-12       Impact factor: 49.962

8.  P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma.

Authors:  Zhe-ping Fang; Bei-ge Jiang; Xue-feng Gu; Bin Zhao; Rui-liang Ge; Fa-biao Zhang
Journal:  Acta Pharmacol Sin       Date:  2013-05-20       Impact factor: 6.150

9.  P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration.

Authors:  Wei Gong; Zhengwen An; Yunling Wang; Xinyan Pan; Weigang Fang; Bo Jiang; Hongquan Zhang
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

Review 10.  Developments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling.

Authors:  Lindsay C Spender; Gareth J Inman
Journal:  Cancer Manag Res       Date:  2014-01-09       Impact factor: 3.989

View more
  19 in total

Review 1.  Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.

Authors:  Yang-Guang Shao; Ke Ning; Feng Li
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 2.  Structure, biochemistry, and biology of PAK kinases.

Authors:  Rakesh Kumar; Rahul Sanawar; Xiaodong Li; Feng Li
Journal:  Gene       Date:  2016-12-19       Impact factor: 3.688

3.  Therapeutic Targeting of Cancer Stem Cells Prevents Resistance of Colorectal Cancer Cells to MEK Inhibition.

Authors:  Astha Lamichhane; Pradip Shahi Thakuri; Sunil Singh; Pouria Rafsanjani Nejad; Jacob Heiss; Gary D Luker; Hossein Tavana
Journal:  ACS Pharmacol Transl Sci       Date:  2022-08-25

Review 4.  Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.

Authors:  Luqing Zhao; Yitao Mao; Jianhua Zhou; Yuelong Zhao; Ya Cao; Xiang Chen
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

5.  Negative Glucocorticoid Response-Like Element from the First Intron of the Chicken Growth Hormone Gene Represses Gene Expression in the Rat Pituitary Tumor Cell Line.

Authors:  Jing-E Ma; Qian-Qian Lang; Feng-Fang Qiu; Li Zhang; Xiang-Guang Li; Wen Luo; Juan Wang; Xing Wang; Xi-Ran Lin; Wen-Sheng Liu; Qing-Hua Nie; Xi-Quan Zhang
Journal:  Int J Mol Sci       Date:  2016-11-09       Impact factor: 5.923

6.  PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.

Authors:  Ying-Chun Zhang; Fu-Chun Huo; Lu-Lu Wei; Chan-Chan Gong; Yao-Jie Pan; Jie Mou; Dong-Sheng Pei
Journal:  J Exp Clin Cancer Res       Date:  2017-10-17

7.  P21-activated kinase 7 (PAK7) interacts with and activates Wnt/β-catenin signaling pathway in breast cancer.

Authors:  Kai Li; Xiaolong Xu; Yanqi He; Yihao Tian; Wenting Pan; Liu Xu; Yanbin Ma; Yang Gao; Jingbo Gao; Yuwen Qi; Lei Wei; Jingwei Zhang
Journal:  J Cancer       Date:  2018-04-22       Impact factor: 4.207

Review 8.  New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.

Authors:  Anushka Dongre; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2019-02       Impact factor: 94.444

9.  PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.

Authors:  Fu-Chun Huo; Yao-Jie Pan; Tong-Tong Li; Jie Mou; Dong-Sheng Pei
Journal:  Cell Death Differ       Date:  2018-08-06       Impact factor: 15.828

10.  MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.

Authors:  Yao-Jie Pan; Lu-Lu Wei; Xiao-Jin Wu; Fu-Chun Huo; Jie Mou; Dong-Sheng Pei
Journal:  Cell Death Dis       Date:  2017-10-26       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.